Edith M. Lord
Impact in
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 67
- Immunotherapy and Immune Responses 45
- Immune Cell Function and Interaction 25
- T-cell and B-cell Immunology 17
- Oncology 45
- Cancer Immunotherapy and Biomarkers 19
- Cancer Cells and Metastasis 14
- CAR-T cell therapy research 13
- Co-authors
- John G. Frelinger (42 shared papers)Scott A. Gerber (19 shared papers)Amit A. Lugade (5 shared papers)C. J. Koch (11 shared papers)Robert C. Rose (2 shared papers)Scott A. Gerber (22 shared papers)Sydney M. Evans (13 shared papers)Elizabeth W. Sorensen (4 shared papers)
- Journals
- The Journal of Immunology (22 papers)International Journal of Cancer (7 papers)Cellular Immunology (6 papers)Radiation Research (6 papers)Journal of Immunological Methods (5 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Edith M. Lord
139 papers receiving 6.0k citations
Edith M. Lord's Hit Papers
Peers
Comparison fields: 5 of 126
- Immunology 2.3k
- Oncology 2.0k
- Cancer Research 949
- Radiology, Nuclear Medicine and Imaging 878
- Biotechnology 263
Countries citing papers authored by Edith M. Lord
This map shows the geographic impact of Edith M. Lord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith M. Lord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith M. Lord more than expected).
Fields of papers citing papers by Edith M. Lord
This network shows the impact of papers produced by Edith M. Lord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith M. Lord. The network helps show where Edith M. Lord may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith M. Lord, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor Hit paper breakdown → | 2005 | 782 |
| 2 | 2008 | 395 | |
| 3 | 1997 | 320 | |
| 4 | Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. | 1993 | 199 |
| 5 | 2013 | 193 | |
| 6 | Detection of hypoxia in human squamous cell carcinoma by EF5 binding. | 2000 | 161 |
| 7 | 2006 | 149 | |
| 8 | 1989 | 128 | |
| 9 | Immunosuppressive activity of human seminal plasma. I. Inhibition of in vitro lymphocyte activation. | 1977 | 125 |
| 10 | 1999 | 107 | |
| 11 | 1977 | 103 | |
| 12 | 2013 | 103 | |
| 13 | 2012 | 92 | |
| 14 | Functional heterogeneity among the T-derived lymphocytes of the mouse. I. Analysis by adult thymectomy. | 1974 | 92 |
| 15 | 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. | 1996 | 91 |
| 16 | 2014 | 88 | |
| 17 | Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. | 2000 | 73 |
| 18 | 2001 | 72 | |
| 19 | 1986 | 72 | |
| 20 | 1999 | 70 |
About Edith M. Lord
Edith M. Lord is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 140 papers that have together received 6.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (45 papers), Immune Cell Function and Interaction (25 papers), Cancer, Hypoxia, and Metabolism (23 papers), Cancer Immunotherapy and Biomarkers (19 papers), T-cell and B-cell Immunology (17 papers), Cancer Cells and Metastasis (14 papers), CAR-T cell therapy research (13 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (2.0k citations), Cancer Research (949 citations), Radiology, Nuclear Medicine and Imaging (878 citations) and Biotechnology (263 citations). Edith M. Lord has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include John G. Frelinger, Scott A. Gerber, Amit A. Lugade, C. J. Koch, Robert C. Rose, Scott A. Gerber, Sydney M. Evans, Elizabeth W. Sorensen, Daniel P. Stites and George F. Sensabaugh. Their work appears in journals such as The Journal of Immunology, International Journal of Cancer, Cellular Immunology, Radiation Research and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.